Free Trial

e.l.f. Beauty (ELF) Financials

e.l.f. Beauty logo
$50.92 -1.06 (-2.04%)
As of 11:52 AM Eastern
Annual Income Statements for e.l.f. Beauty

Annual Income Statements for e.l.f. Beauty

This table shows e.l.f. Beauty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
4.36 5.31 33 16 18 6.23 22 62 128 112 26
Consolidated Net Income / (Loss)
4.36 5.31 33 16 18 6.23 22 62 128 112 26
Net Income / (Loss) Continuing Operations
4.36 5.31 33 16 18 6.23 22 62 128 112 26
Total Pre-Tax Income
8.68 9.81 22 18 24 3.69 25 64 141 145 40
Total Operating Income
26 23 33 26 30 9.40 30 68 150 158 74
Total Gross Profit
100 132 165 163 181 206 252 390 724 936 1,157
Total Revenue
191 230 270 267 283 318 392 579 1,024 1,314 1,636
Operating Revenue
191 230 270 267 283 318 392 579 1,024 1,314 1,636
Total Cost of Revenue
91 97 105 105 102 112 140 188 300 378 479
Operating Cost of Revenue
91 97 105 105 102 112 140 188 300 378 479
Total Operating Expenses
75 109 131 137 151 197 222 322 574 778 1,084
Selling, General & Admin Expense
75 109 131 137 157 194 222 322 574 778 1,026
Other Special Charges / (Income)
- - - - - - - - 0.00 0.00 58
Total Other Income / (Expense), net
-17 -13 -11 -8.21 -5.88 -5.71 -4.34 -4.07 -8.69 -13 -33
Interest Expense
13 16 8.78 7.82 6.31 4.09 0.46 0.18 0.00 0.01 0.67
Interest & Investment Income
- - - - - - -2.44 -2.02 -9.90 -14 -35
Other Income / (Expense), net
-4.17 3.02 -2.04 -0.39 0.43 -1.62 -1.44 -1.88 1.21 1.29 2.79
Income Tax Expense
4.32 4.50 -11 2.43 6.19 -2.54 3.66 2.54 13 33 14
Basic Earnings per Share
($1,559.81) ($39.47) $0.74 $0.33 $0.37 $0.13 $0.43 $1.17 $2.33 $1.99 $0.45
Weighted Average Basic Shares Outstanding
30.52K 12.61M 45.36M 46.83M 48.50M 49.38M 50.94M 52.47M 54.75M 56.21M 58.26M
Diluted Earnings per Share
($1,559.81) ($39.47) $0.68 $0.32 $0.35 $0.12 $0.41 $1.11 $2.21 $1.92 $0.44
Weighted Average Diluted Shares Outstanding
30.52K 12.61M 49.37M 49.27M 50.82M 51.99M 53.65M 55.34M 57.79M 58.35M 59.35M
Weighted Average Basic & Diluted Shares Outstanding
0.00 -100K 45.36M 48.82M 50.01M 51.65M 52.27M 53.87M 55.94M 56.33M 59.44M

Quarterly Income Statements for e.l.f. Beauty

This table shows e.l.f. Beauty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
33 27 15 48 19 17 28 33 3.00 39 -49
Consolidated Net Income / (Loss)
33 27 15 48 19 17 28 33 3.00 39 -49
Net Income / (Loss) Continuing Operations
33 27 15 48 19 17 28 33 3.00 39 -49
Total Pre-Tax Income
40 30 11 47 28 26 44 51 -3.99 54 -61
Total Operating Income
40 32 17 51 28 35 44 49 7.72 68 -50
Total Gross Profit
152 192 227 231 214 253 237 245 239 347 326
Total Revenue
216 271 321 324 301 355 333 354 344 490 449
Operating Revenue
216 271 321 324 301 355 333 354 344 490 449
Total Cost of Revenue
63 79 94 93 87 102 96 109 105 142 123
Operating Cost of Revenue
63 79 94 93 87 102 96 109 105 142 123
Total Operating Expenses
112 160 210 181 186 218 193 196 231 280 377
Selling, General & Admin Expense
112 160 210 181 186 218 193 196 231 280 319
Total Other Income / (Expense), net
-0.44 -1.42 -5.85 -3.48 0.03 -8.81 -0.28 2.41 -12 -14 -10
Interest & Investment Income
0.62 -3.99 -4.53 -3.67 -3.76 -3.53 -2.86 -2.63 -9.15 -12 -11
Other Income / (Expense), net
-1.06 2.57 -0.69 0.19 3.79 -5.28 2.59 5.04 -1.88 -1.33 0.95
Income Tax Expense
6.47 3.53 -3.35 -0.33 8.93 9.02 16 18 -6.99 14 -11
Basic Earnings per Share
$0.61 $0.49 $0.25 $0.85 $0.34 $0.31 $0.49 $0.59 $0.05 $0.66 ($0.85)
Weighted Average Basic Shares Outstanding
54.43M 55.14M 54.75M 55.97M 56.35M 56.36M 56.21M 56.33M 58.36M 59.29M 58.26M
Diluted Earnings per Share
$0.58 $0.46 $0.24 $0.81 $0.33 $0.30 $0.48 $0.58 $0.05 $0.65 ($0.84)
Weighted Average Diluted Shares Outstanding
57.44M 58.03M 57.79M 58.55M 58.48M 58.35M 58.35M 57.68M 59.59M 60.19M 59.35M
Weighted Average Basic & Diluted Shares Outstanding
55.20M 55.51M 55.94M 56.39M 56.33M 56.40M 56.33M 56.73M 59.64M 59.05M 59.44M

Annual Cash Flow Statements for e.l.f. Beauty

This table details how cash moves in and out of e.l.f. Beauty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents
9.34 1.29 -5.24 41 -7.71 12 -14 77 -13 41 141
Net Cash From Operating Activities
25 2.12 12 56 44 29 20 102 71 134 213
Net Cash From Continuing Operating Activities
25 2.12 12 56 44 29 20 102 71 134 213
Net Income / (Loss) Continuing Operations
4.36 5.31 33 16 18 6.23 22 62 128 112 26
Consolidated Net Income / (Loss)
4.36 5.31 33 16 18 6.23 22 62 128 112 26
Depreciation Expense
10 13 15 18 23 25 27 18 30 44 79
Amortization Expense
1.07 1.28 0.81 0.79 0.75 0.85 0.39 0.35 0.43 0.55 1.43
Non-Cash Adjustments To Reconcile Net Income
5.82 -0.82 13 17 9.51 22 20 34 39 82 51
Changes in Operating Assets and Liabilities, net
2.99 -17 -50 4.58 -6.67 -25 -50 -11 -126 -104 54
Net Cash From Investing Activities
-10 -9.14 -10 -8.87 -35 -6.47 -4.82 -1.72 -285 -19 -605
Net Cash From Continuing Investing Activities
-10 -9.14 -10 -8.87 -35 -6.47 -4.82 -1.72 -285 -19 -605
Purchase of Property, Plant & Equipment
-10 -9.22 -7.54 -8.87 -9.42 -6.47 -4.82 -1.72 -8.66 -19 -22
Acquisitions
- - 0.00 0.00 -26 - 0.00 0.00 -275 0.00 -582
Purchase of Investments
0.00 0.00 -2.88 - - - 0.00 0.00 -1.03 -0.58 -1.12
Net Cash From Financing Activities
-4.94 8.31 -7.20 -5.56 -17 -11 -29 -23 201 -74 534
Net Cash From Continuing Financing Activities
-4.94 8.31 -7.20 -5.56 -17 -11 -29 -23 201 -74 534
Repayment of Debt
-32 -166 -35 -11 -10 -33 -83 -31 -9.12 -265 -72
Repurchase of Common Equity
- - 0.00 0.00 -7.90 - - 0.00 0.00 -67 -50
Issuance of Debt
27 186 26 2.00 0.00 20 52 0.00 205 257 650
Issuance of Common Equity
0.03 64 1.98 3.18 1.49 1.50 1.68 8.05 5.56 0.95 5.80
Effect of Exchange Rate Changes
- - - - - - - 0.00 -0.03 0.22 -0.19
Cash Interest Paid
12 12 8.16 7.12 12 3.16 1.76 3.58 11 16 37
Cash Income Taxes Paid
7.79 8.47 5.67 4.09 0.18 2.30 7.57 13 12 25 21

Quarterly Cash Flow Statements for e.l.f. Beauty

This table details how cash moves in and out of e.l.f. Beauty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
25 -93 33 0.85 -12 -23 75 21 29 -2.58 93
Net Cash From Operating Activities
28 -17 37 1.28 11 -15 136 27 23 59 102
Net Cash From Continuing Operating Activities
28 -17 37 1.28 11 -15 136 27 23 59 102
Net Income / (Loss) Continuing Operations
33 27 15 48 19 17 28 33 3.00 39 -49
Consolidated Net Income / (Loss)
33 27 15 48 19 17 28 33 3.00 39 -49
Depreciation Expense
6.67 8.13 12 9.06 13 7.10 13 13 18 22 26
Amortization Expense
0.07 0.14 0.14 0.14 0.14 0.14 0.13 0.13 0.35 0.48 0.47
Non-Cash Adjustments To Reconcile Net Income
11 4.30 12 15 22 29 18 13 -14 33 20
Changes in Operating Assets and Liabilities, net
-23 -57 -1.64 -71 -42 -69 77 -32 16 -35 105
Net Cash From Investing Activities
-0.85 -279 -3.70 -0.88 -1.62 -5.24 -11 -7.56 -587 -7.94 -2.30
Net Cash From Continuing Investing Activities
-0.85 -279 -3.70 -0.88 -1.62 -5.24 -11 -7.56 -587 -7.94 -2.30
Purchase of Property, Plant & Equipment
-0.85 -4.52 -2.68 -0.79 -1.62 -5.05 -11 -7.10 -6.85 -6.62 -1.89
Net Cash From Financing Activities
-1.85 204 -0.11 0.41 -22 -2.30 -50 0.12 595 -54 -7.00
Net Cash From Continuing Financing Activities
-1.85 204 -0.11 0.41 -22 -2.30 -50 0.12 595 -54 -7.00
Repayment of Debt
-2.12 -2.77 -2.77 -0.06 -5.38 -2.69 -257 0.00 -57 -7.50 -7.50
Issuance of Common Equity
- - 2.67 0.46 - - - 0.12 1.65 3.53 0.50
Effect of Exchange Rate Changes
- -0.06 0.02 0.04 0.57 -0.68 0.28 1.54 -1.35 -0.09 -0.29

Annual Balance Sheets for e.l.f. Beauty

This table presents e.l.f. Beauty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets
361 415 417 436 453 487 495 596 1,129 1,248 2,394
Total Current Assets
71 125 124 142 132 170 193 303 477 541 789
Cash & Equivalents
14 15 10 51 46 58 43 121 108 149 290
Accounts Receivable
22 38 45 37 30 40 46 68 124 126 175
Inventories, net
31 69 63 46 46 57 84 81 191 187 220
Prepaid Expenses
2.98 2.39 6.27 7.47 10 15 20 33 54 79 105
Plant, Property, & Equipment, net
9.85 17 18 22 17 14 11 7.87 14 29 41
Total Noncurrent Assets
281 273 276 272 304 303 291 284 638 679 1,563
Goodwill
157 157 157 157 171 172 172 172 341 341 853
Intangible Assets
121 113 106 99 102 94 86 78 225 208 553
Other Noncurrent Operating Assets
1.95 2.41 9.54 13 27 35 30 35 73 131 157
Total Liabilities & Shareholders' Equity
361 415 417 436 453 487 495 596 1,129 1,248 2,394
Total Liabilities
224 274 223 207 211 218 182 185 487 487 1,264
Total Current Liabilities
46 80 51 43 51 73 65 108 299 177 336
Short-Term Debt
10 8.65 8.65 9.86 13 16 5.79 5.58 100 0.00 56
Accounts Payable
11 38 27 20 12 16 19 31 81 72 97
Accrued Expenses
14 34 16 13 26 41 40 71 118 105 182
Total Noncurrent Liabilities
178 194 172 164 160 144 117 77 188 310 927
Long-Term Debt
135 156 148 141 126 110 91 61 162 257 809
Noncurrent Deferred & Payable Income Tax Liabilities
42 34 21 20 22 13 9.59 3.74 3.67 3.81 6.20
Other Noncurrent Operating Liabilities
1.60 3.21 2.98 2.77 12 21 17 12 22 50 112
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-60 141 194 229 242 270 312 411 643 761 1,131
Total Preferred & Common Equity
-60 141 194 229 242 270 312 411 643 761 1,131
Total Common Equity
-60 141 194 229 242 270 312 411 643 761 1,131
Common Stock
6.79 701 721 741 754 775 796 833 937 943 1,286
Retained Earnings
-67 -560 -527 -512 -512 -505 -484 -422 -294 -182 -156
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - 0.00 -0.05 0.52 0.88

Quarterly Balance Sheets for e.l.f. Beauty

This table presents e.l.f. Beauty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2022 12/31/2022 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2024 12/31/2024 6/30/2025 9/30/2025 12/31/2025
Total Assets
542 556 658 747 1,108 1,205 1,237 1,265 1,315 2,319 2,324
Total Current Assets
247 263 370 435 455 530 554 559 603 707 702
Cash & Equivalents
85 87 143 168 73 109 97 74 170 194 197
Accounts Receivable
54 66 91 87 121 156 147 188 173 155 190
Inventories, net
81 81 98 147 205 200 239 215 170 247 221
Prepaid Expenses
27 28 39 34 57 66 72 83 89 111 94
Plant, Property, & Equipment, net
8.93 8.73 7.58 7.62 13 14 16 20 39 44 45
Total Noncurrent Assets
286 284 280 304 641 660 667 686 673 1,567 1,577
Goodwill
172 172 172 172 340 341 341 341 341 852 853
Intangible Assets
82 80 76 74 231 221 216 212 203 575 564
Other Noncurrent Operating Assets
29 30 32 58 70 99 110 133 129 140 160
Total Liabilities & Shareholders' Equity
542 556 658 747 1,108 1,205 1,237 1,265 1,315 2,319 2,324
Total Liabilities
185 171 186 231 494 501 509 497 510 1,180 1,162
Total Current Liabilities
72 88 110 152 303 300 311 294 185 262 254
Short-Term Debt
5.80 5.69 5.43 5.23 100 103 100 100 0.00 23 30
Accounts Payable
19 32 53 64 73 80 94 65 75 109 74
Accrued Expenses
47 50 51 83 130 117 117 128 110 130 150
Total Noncurrent Liabilities
113 83 76 78 191 201 198 204 325 918 908
Long-Term Debt
88 62 60 58 164 159 157 154 257 832 817
Noncurrent Deferred & Payable Income Tax Liabilities
11 7.78 5.86 4.90 4.28 7.91 4.83 0.49 17 21 17
Other Noncurrent Operating Liabilities
14 13 11 16 22 34 37 49 52 65 74
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
357 385 472 516 614 704 728 767 805 1,139 1,162
Total Preferred & Common Equity
357 385 472 516 614 704 728 767 805 1,139 1,162
Total Common Equity
357 385 472 516 614 704 728 767 805 1,139 1,162
Common Stock
814 824 841 852 923 950 955 978 953 1,284 1,267
Retained Earnings
-457 -438 -369 -336 -309 -247 -228 -211 -149 -146 -107
Accumulated Other Comprehensive Income / (Loss)
- 0.00 0.00 0.00 -0.06 -0.01 0.44 0.18 1.21 0.97 1.03

Annual Metrics And Ratios for e.l.f. Beauty

This table displays calculated financial ratios and metrics derived from e.l.f. Beauty's official financial filings.

Metric 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 59,052,239.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 59,052,239.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.45
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 19.93% 17.56% -0.91% 0.00% 12.47% 23.28% 47.61% 76.89% 28.28% 24.59%
EBITDA Growth
0.00% 23.72% 14.92% -4.62% 0.00% -37.36% 65.09% 59.07% 110.90% 12.40% -22.93%
EBIT Growth
0.00% 21.95% 19.73% -17.51% 0.00% -74.39% 264.16% 133.90% 127.69% 5.59% -52.04%
NOPAT Growth
0.00% -2.66% 296.74% -54.38% 0.00% -28.66% 60.53% 156.77% 107.11% -10.17% -60.66%
Net Income Growth
0.00% 21.94% 530.06% -53.62% 0.00% -65.15% 249.33% 182.64% 107.48% -12.20% -76.52%
EPS Growth
0.00% 97.47% 101.72% -52.94% 0.00% -65.71% 241.67% 170.73% 99.10% -13.12% -77.08%
Operating Cash Flow Growth
0.00% -91.35% 483.87% 349.04% 0.00% -33.48% -33.80% 422.13% -30.16% 88.10% 58.78%
Free Cash Flow Firm Growth
0.00% 0.00% 126.74% 1,170.34% 0.00% 0.00% -116.86% 3,613.81% -523.75% 116.24% -1,697.92%
Invested Capital Growth
0.00% 8.43% 16.14% -3.45% 0.00% 1.13% 8.20% -1.76% 123.30% 9.08% 96.40%
Revenue Q/Q Growth
0.00% 0.00% 1.95% -1.12% 0.00% 5.98% 3.28% 16.56% 15.03% 0.88% 7.68%
EBITDA Q/Q Growth
0.00% 0.00% -1.18% -1.61% 0.00% -6.55% 7.52% 6.67% 8.10% 16.12% -34.51%
EBIT Q/Q Growth
0.00% 0.00% -3.87% -6.62% 0.00% -26.37% 14.67% 11.18% 5.58% 23.75% -55.75%
NOPAT Q/Q Growth
0.00% 0.00% 68.86% -42.03% 0.00% 29.77% 5.40% 27.83% 2.80% 6.63% -60.29%
Net Income Q/Q Growth
0.00% 0.00% 80.01% -43.20% 0.00% 5.36% 7.83% 31.36% -1.33% 13.95% -74.68%
EPS Q/Q Growth
0.00% 0.00% -99.69% -42.86% 0.00% 9.09% 7.89% 30.59% -2.21% 14.29% -75.00%
Operating Cash Flow Q/Q Growth
0.00% -91.06% 287.66% 3.74% 0.00% 248.28% -44.80% 26.27% 6.17% 285.10% -13.67%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -11.66% 0.00% 0.00% -116.78% 28.52% 1.86% 280.59% -6.24%
Invested Capital Q/Q Growth
0.00% 0.00% 3.07% -0.56% 0.00% -5.74% -1.33% -1.81% -1.07% -8.34% -5.81%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
52.41% 57.60% 61.03% 60.85% 64.03% 64.82% 64.19% 67.44% 70.72% 71.24% 70.72%
EBITDA Margin
17.11% 17.65% 17.26% 16.61% 19.08% 10.63% 14.23% 15.34% 18.29% 15.53% 9.61%
Operating Margin
13.36% 10.05% 12.33% 9.78% 10.59% 2.96% 7.59% 11.77% 14.62% 12.03% 4.50%
EBIT Margin
11.18% 11.37% 11.58% 9.64% 10.74% 2.45% 7.22% 11.45% 14.74% 12.13% 4.67%
Profit (Net Income) Margin
2.28% 2.31% 12.40% 5.81% 6.32% 1.96% 5.55% 10.63% 12.47% 8.53% 1.61%
Tax Burden Percent
50.21% 54.15% 148.98% 86.46% 74.30% 168.89% 85.60% 96.03% 90.55% 77.04% 65.05%
Interest Burden Percent
40.55% 37.60% 71.91% 69.67% 79.24% 47.43% 89.76% 96.69% 93.44% 91.32% 52.95%
Effective Tax Rate
49.79% 45.85% -48.98% 13.54% 25.70% -68.89% 14.40% 3.97% 9.45% 22.96% 34.95%
Return on Invested Capital (ROIC)
4.79% 4.48% 15.80% 6.82% 6.71% 4.76% 7.30% 18.18% 23.50% 14.62% 3.72%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.68% -0.65% 4.80% 0.91% 1.83% -7.64% 0.92% 230.31% 7.71% 7.25% -2.59%
Return on Net Nonoperating Assets (RNNOA)
-1.61% -0.65% 4.20% 0.51% 0.68% -2.32% 0.18% -1.17% 0.73% 1.35% -0.94%
Return on Equity (ROE)
3.18% 3.83% 20.00% 7.34% 7.38% 2.44% 7.48% 17.01% 24.23% 15.97% 2.78%
Cash Return on Invested Capital (CROIC)
0.00% -3.61% 0.86% 10.34% 0.00% 3.63% -0.59% 19.95% -52.77% 5.94% -61.33%
Operating Return on Assets (OROA)
5.93% 6.73% 7.51% 6.04% 6.70% 1.65% 5.77% 12.16% 17.50% 13.40% 4.20%
Return on Assets (ROA)
1.21% 1.37% 8.05% 3.64% 3.95% 1.33% 4.43% 11.29% 14.80% 9.43% 1.45%
Return on Common Equity (ROCE)
-1.40% 1.11% 20.00% 7.34% 7.38% 2.44% 7.48% 17.01% 24.23% 15.97% 2.78%
Return on Equity Simple (ROE_SIMPLE)
-7.21% 3.77% 17.27% 6.77% 7.38% 2.31% 6.97% 14.97% 19.87% 14.73% 0.00%
Net Operating Profit after Tax (NOPAT)
13 12 50 23 22 16 25 65 136 122 48
NOPAT Margin
6.71% 5.44% 18.37% 8.46% 7.87% 4.99% 6.50% 11.30% 13.24% 9.27% 2.93%
Net Nonoperating Expense Percent (NNEP)
6.48% 5.12% 11.00% 5.92% 4.88% 12.40% 6.37% -212.13% 15.79% 7.37% 6.31%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 11.96% 2.40%
Cost of Revenue to Revenue
47.59% 42.40% 38.97% 39.15% 35.97% 35.18% 35.81% 32.56% 29.28% 28.76% 29.28%
SG&A Expenses to Revenue
39.06% 47.55% 48.70% 51.07% 55.56% 61.03% 56.59% 55.67% 56.10% 59.20% 62.70%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
39.06% 47.55% 48.70% 51.07% 53.45% 61.86% 56.60% 55.67% 56.10% 59.20% 66.22%
Earnings before Interest and Taxes (EBIT)
21 26 31 26 30 7.78 28 66 151 159 76
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
33 41 47 44 54 34 56 89 187 204 157
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 9.30 5.32 1.82 2.03 5.10 4.31 10.68 16.93 4.65 3.17
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 367.59 24.64 27.20 141.54 16.66 0.00
Price to Revenue (P/Rev)
0.00 5.71 3.82 1.56 1.74 4.32 3.43 7.58 10.63 2.70 2.19
Price to Earnings (P/E)
0.00 246.52 30.83 26.92 27.49 220.60 61.84 71.33 85.23 31.59 136.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.41% 3.24% 3.72% 3.64% 0.45% 1.62% 1.40% 1.17% 3.17% 0.74%
Enterprise Value to Invested Capital (EV/IC)
0.00 5.03 3.49 1.58 1.75 4.29 3.85 12.15 13.85 4.20 2.43
Enterprise Value to Revenue (EV/Rev)
0.00 6.36 4.36 1.92 2.05 4.53 3.56 7.49 10.78 2.78 2.54
Enterprise Value to EBITDA (EV/EBITDA)
0.00 36.01 25.24 11.57 10.77 42.62 25.03 48.82 58.94 17.89 26.43
Enterprise Value to EBIT (EV/EBIT)
0.00 55.92 37.62 19.95 19.13 185.18 49.31 65.41 73.13 22.91 54.37
Enterprise Value to NOPAT (EV/NOPAT)
0.00 116.77 23.71 22.73 26.12 90.75 54.81 66.24 81.42 29.97 86.75
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 688.34 94.96 9.25 13.12 48.88 71.59 42.54 155.09 27.27 19.55
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 435.83 15.01 0.00 118.85 0.00 60.36 0.00 73.84 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.06 1.17 0.81 0.66 0.57 0.47 0.31 0.16 0.41 0.34 0.77
Long-Term Debt to Equity
0.98 1.11 0.76 0.61 0.52 0.41 0.29 0.15 0.25 0.34 0.72
Financial Leverage
0.96 1.01 0.88 0.57 0.37 0.30 0.20 -0.01 0.09 0.19 0.36
Leverage Ratio
2.64 2.79 2.49 2.02 1.87 1.84 1.69 1.51 1.64 1.69 1.93
Compound Leverage Factor
1.07 1.05 1.79 1.40 1.48 0.87 1.51 1.46 1.53 1.55 1.02
Debt to Total Capital
51.42% 53.92% 44.64% 39.60% 36.41% 31.94% 23.67% 13.92% 28.97% 25.23% 43.36%
Short-Term Debt to Total Capital
3.66% 2.83% 2.47% 2.60% 3.30% 4.11% 1.41% 1.17% 11.09% 0.00% 2.82%
Long-Term Debt to Total Capital
47.76% 51.09% 42.18% 37.01% 33.11% 27.83% 22.25% 12.75% 17.89% 25.23% 40.55%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
70.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-21.43% 46.08% 55.36% 60.40% 63.59% 68.06% 76.33% 86.08% 71.03% 74.77% 56.64%
Debt to EBITDA
4.42 4.07 3.36 3.39 2.57 3.74 1.74 0.75 1.40 1.26 5.51
Net Debt to EBITDA
4.00 3.69 3.08 2.17 1.66 1.95 0.91 -0.61 0.82 0.53 3.66
Long-Term Debt to EBITDA
4.11 3.85 3.17 3.16 2.34 3.26 1.63 0.69 0.86 1.26 5.15
Debt to NOPAT
11.29 13.19 3.15 6.65 6.23 7.97 3.80 1.02 1.93 2.11 18.07
Net Debt to NOPAT
10.20 11.97 2.89 4.26 4.03 4.15 1.99 -0.83 1.14 0.89 12.02
Long-Term Debt to NOPAT
10.48 12.50 2.98 6.21 5.67 6.95 3.57 0.93 1.19 2.11 16.90
Altman Z-Score
0.00 1.87 2.11 0.65 0.88 3.28 4.36 15.01 14.59 5.98 2.62
Noncontrolling Interest Sharing Ratio
144.12% 71.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.54 1.56 2.41 3.30 2.59 2.32 2.97 2.81 1.60 3.05 2.35
Quick Ratio
0.80 0.66 1.06 2.04 1.48 1.34 1.37 1.75 0.78 1.55 1.38
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -10 2.70 34 0.00 12 -2.04 72 -304 49 -790
Operating Cash Flow to CapEx
241.76% 22.99% 164.08% 626.49% 470.31% 455.28% 405.00% 5,913.12% 821.73% 722.68% 946.64%
Free Cash Flow to Firm to Interest Expense
0.00 -0.62 0.31 4.38 0.00 2.96 -4.44 408.01 0.00 3,801.51 -1,171.64
Operating Cash Flow to Interest Expense
1.93 0.13 1.41 7.11 7.03 7.21 42.42 578.88 0.00 10,295.38 315.30
Operating Cash Flow Less CapEx to Interest Expense
1.13 -0.44 0.55 5.98 5.53 5.62 31.95 569.09 0.00 8,870.77 281.99
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.59 0.65 0.63 0.62 0.68 0.80 1.06 1.19 1.11 0.90
Accounts Receivable Turnover
8.52 7.61 6.55 6.57 9.52 9.10 9.15 10.20 10.68 10.52 10.89
Inventory Turnover
2.91 1.93 1.59 1.92 2.20 2.17 1.99 2.27 2.20 2.00 2.35
Fixed Asset Turnover
19.42 17.00 15.34 13.43 16.47 20.56 32.21 62.74 93.73 61.44 46.57
Accounts Payable Turnover
8.20 3.97 3.25 4.43 8.21 7.97 8.04 7.44 5.33 4.93 5.65
Days Sales Outstanding (DSO)
42.86 47.94 55.76 55.52 38.35 40.11 39.91 35.78 34.17 34.71 33.53
Days Inventory Outstanding (DIO)
125.27 188.74 229.20 190.04 165.80 168.00 183.65 160.59 166.05 182.90 155.19
Days Payable Outstanding (DPO)
44.54 91.99 112.32 82.38 44.46 45.81 45.39 49.06 68.48 74.03 64.62
Cash Conversion Cycle (CCC)
123.59 144.69 172.65 163.18 159.70 162.30 178.17 147.32 131.75 143.58 124.10
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
268 290 337 326 332 336 363 357 797 869 1,706
Invested Capital Turnover
0.71 0.82 0.86 0.81 0.85 0.95 1.12 1.61 1.78 1.58 1.27
Increase / (Decrease) in Invested Capital
0.00 23 47 -12 0.00 3.75 28 -6.37 440 72 838
Enterprise Value (EV)
0.00 1,459 1,175 514 581 1,441 1,397 4,334 11,035 3,649 4,155
Market Capitalization
0.00 1,310 1,032 418 492 1,375 1,346 4,389 10,881 3,541 3,579
Book Value per Share
($1,978.77) $3.11 $4.19 $4.75 $4.85 $5.26 $5.99 $7.71 $11.58 $13.49 $19.14
Tangible Book Value per Share
($11,104.54) ($2.86) ($1.50) ($0.55) ($0.63) $0.07 $1.05 $3.03 $1.39 $3.77 ($4.67)
Total Capital
282 306 350 380 381 396 409 477 905 1,018 1,996
Total Debt
145 165 156 150 139 127 97 66 262 257 866
Total Long-Term Debt
135 156 148 141 126 110 91 61 162 257 809
Net Debt
131 150 143 96 90 66 51 -54 154 108 576
Capital Expenditures (CapEx)
10 9.22 7.54 8.87 9.42 6.47 4.82 1.72 8.66 19 22
Debt-free, Cash-free Net Working Capital (DFCFNWC)
21 38 71 57 48 55 90 80 170 215 220
Debt-free Net Working Capital (DFNWC)
35 53 81 109 94 113 134 201 278 364 509
Net Working Capital (NWC)
25 45 72 99 81 97 128 195 178 364 453
Net Nonoperating Expense (NNE)
8.48 7.18 16 7.10 4.37 9.64 3.71 3.91 7.87 9.65 22
Net Nonoperating Obligations (NNO)
131 150 143 96 90 66 51 -54 154 108 576
Total Depreciation and Amortization (D&A)
11 14 15 19 24 26 27 23 36 45 81
Debt-free, Cash-free Net Working Capital to Revenue
11.07% 16.55% 26.26% 21.46% 16.84% 17.39% 23.06% 13.85% 16.61% 16.35% 13.43%
Debt-free Net Working Capital to Revenue
18.38% 23.21% 29.99% 40.60% 33.16% 35.55% 34.12% 34.71% 27.18% 27.67% 31.13%
Net Working Capital to Revenue
12.99% 19.44% 26.78% 36.92% 28.72% 30.43% 32.64% 33.75% 17.38% 27.67% 27.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1,559.81) ($39.47) $0.74 $0.33 $0.00 $0.13 $0.43 $1.17 $2.33 $1.99 $0.45
Adjusted Weighted Average Basic Shares Outstanding
30.52K 12.61M 45.36M 46.83M 0.00 49.38M 50.94M 52.47M 54.75M 56.21M 58.26M
Adjusted Diluted Earnings per Share
($1,559.81) ($39.47) $0.68 $0.32 $0.00 $0.12 $0.41 $1.11 $2.21 $1.92 $0.44
Adjusted Weighted Average Diluted Shares Outstanding
30.52K 12.61M 49.37M 49.27M 0.00 51.99M 53.65M 55.34M 57.79M 58.35M 59.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 45.66M 46.76M 48.82M 0.00 51.65M 52.27M 53.87M 55.94M 56.33M 59.44M
Normalized Net Operating Profit after Tax (NOPAT)
13 12 23 23 18 8.43 26 65 136 122 85
Normalized NOPAT Margin
6.71% 5.44% 8.63% 8.46% 6.30% 2.65% 6.51% 11.30% 13.24% 9.27% 5.22%
Pre Tax Income Margin
4.53% 4.27% 8.33% 6.71% 8.51% 1.16% 6.48% 11.07% 13.77% 11.08% 2.47%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.68 1.60 3.56 3.30 4.82 1.90 61.59 376.52 0.00 12,255.46 113.38
NOPAT to Interest Expense
1.01 0.77 5.65 2.89 3.53 3.88 55.40 371.80 0.00 9,364.89 71.06
EBIT Less CapEx to Interest Expense
0.88 1.04 2.70 2.16 3.32 0.32 51.12 366.73 0.00 10,830.85 80.07
NOPAT Less CapEx to Interest Expense
0.21 0.20 4.79 1.76 2.03 2.30 44.93 362.01 0.00 7,940.28 37.76
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 1,279.88% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 1,279.88% 0.00% 0.00% 44.20% 0.00% 0.00% 0.00% 0.00% 59.83% 189.93%

Quarterly Metrics And Ratios for e.l.f. Beauty

This table displays calculated financial ratios and metrics derived from e.l.f. Beauty's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 59,052,239.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 59,052,239.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -0.84
Growth Metrics
- - - - - - - - - - -
Revenue Growth
76.14% 84.90% 71.41% 49.99% 39.71% 31.14% 3.58% 9.02% 14.24% 37.76% 35.07%
EBITDA Growth
134.53% 44.51% 99.49% -6.86% -2.94% -13.21% 129.99% 11.62% -41.84% 112.42% -137.48%
EBIT Growth
177.13% 43.21% 95.31% -16.61% -18.94% -13.35% 187.12% 5.60% -81.59% 122.15% -205.27%
NOPAT Growth
149.00% 47.88% 39.82% -5.18% -43.52% -18.12% 28.50% -37.83% -71.57% 114.26% -223.92%
Net Income Growth
184.12% 40.74% -10.58% -10.23% -42.83% -35.80% 94.49% -29.95% -84.25% 128.12% -274.72%
EPS Growth
176.19% 35.29% -17.24% -12.90% -43.10% -34.78% 100.00% -28.40% -84.85% 116.67% -275.00%
Operating Cash Flow Growth
123.90% -166.00% 12.57% -94.51% -59.99% 14.14% 267.69% 2,025.92% 109.66% 503.87% -24.72%
Free Cash Flow Firm Growth
-213.81% -1,849.62% -1,981.75% -3,158.31% -2,920.50% 71.44% 89.49% 99.26% -98.04% -587.38% -1,888.55%
Invested Capital Growth
13.44% 121.96% 123.30% 117.34% 115.69% 17.55% 9.08% 4.06% 102.59% 91.14% 96.40%
Revenue Q/Q Growth
-0.38% 25.72% 18.53% 1.04% -7.21% 18.02% -6.38% 6.34% -2.77% 42.32% -8.22%
EBITDA Q/Q Growth
-31.28% -6.95% -39.45% 120.89% -28.39% -16.79% 62.68% 11.31% -63.51% 260.52% -125.59%
EBIT Q/Q Growth
-35.91% -12.06% -52.51% 211.51% -37.70% -6.00% 57.38% 14.57% -89.14% 1,034.21% -174.58%
NOPAT Q/Q Growth
-37.53% -16.34% -21.38% 130.75% -62.79% 21.29% 23.38% 11.65% -82.98% 814.12% -171.36%
Net Income Q/Q Growth
-37.20% -19.18% -45.97% 227.36% -60.00% -9.25% 63.68% 17.90% -91.01% 1,214.29% -225.37%
EPS Q/Q Growth
-37.63% -20.69% -47.83% 237.50% -59.26% -9.09% 60.00% 20.83% -91.38% 1,200.00% -229.23%
Operating Cash Flow Q/Q Growth
19.53% -161.37% 316.07% -96.54% 771.82% -231.71% 1,025.28% -79.99% -14.02% 153.70% 72.47%
Free Cash Flow Firm Q/Q Growth
-212.50% -2,641.05% -0.95% 1.49% -11.11% 74.08% 62.96% 93.10% -29,808.47% 10.04% -7.16%
Invested Capital Q/Q Growth
4.42% 95.88% -1.07% 7.56% 3.63% 6.76% -8.34% 2.61% 101.76% 0.73% -5.81%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
70.70% 70.85% 70.75% 71.28% 71.10% 71.29% 71.26% 69.13% 69.45% 70.99% 72.66%
EBITDA Margin
21.28% 15.75% 8.76% 19.16% 14.79% 10.42% 18.11% 18.96% 7.12% 18.03% -5.03%
Operating Margin
18.64% 11.75% 5.30% 15.63% 9.27% 9.87% 13.32% 13.77% 2.24% 13.80% -11.20%
EBIT Margin
18.15% 12.70% 5.09% 15.69% 10.53% 8.39% 14.10% 15.19% 1.70% 13.53% -10.99%
Profit (Net Income) Margin
15.44% 9.92% 4.52% 14.66% 6.32% 4.86% 8.49% 9.42% 0.87% 8.04% -10.99%
Tax Burden Percent
83.72% 88.40% 129.93% 100.69% 68.06% 65.68% 64.16% 65.17% -75.11% 73.10% 81.55%
Interest Burden Percent
101.59% 88.42% 68.44% 92.80% 88.14% 88.17% 93.88% 95.10% -68.33% 81.35% 122.58%
Effective Tax Rate
16.28% 11.60% -29.93% -0.69% 31.95% 34.32% 35.84% 34.83% 0.00% 26.90% 0.00%
Return on Invested Capital (ROIC)
30.87% 15.81% 12.24% 28.48% 11.83% 9.63% 13.48% 13.79% 1.62% 11.11% -9.97%
ROIC Less NNEP Spread (ROIC-NNEP)
31.61% 14.33% -3.02% 19.22% 11.90% 6.52% 13.35% 15.09% 1.03% 8.70% -14.10%
Return on Net Nonoperating Assets (RNNOA)
-3.58% 2.44% -0.29% 1.24% 0.53% 1.76% 2.49% 2.40% 0.45% 3.75% -5.10%
Return on Equity (ROE)
27.29% 18.25% 11.95% 29.72% 12.36% 11.39% 15.97% 16.18% 2.07% 14.86% -15.06%
Cash Return on Invested Capital (CROIC)
19.07% -53.22% -52.77% -52.71% -55.15% -3.12% 5.94% 7.71% -60.76% -53.87% -61.33%
Operating Return on Assets (OROA)
21.56% 13.58% 6.04% 19.07% 12.93% 9.21% 15.58% 16.19% 1.32% 11.46% -9.88%
Return on Assets (ROA)
18.34% 10.62% 5.37% 17.81% 7.75% 5.33% 9.39% 10.04% 0.68% 6.81% -9.87%
Return on Common Equity (ROCE)
27.29% 18.25% 11.95% 29.72% 12.36% 11.39% 15.97% 16.18% 2.07% 14.86% -15.06%
Return on Equity Simple (ROE_SIMPLE)
23.55% 21.06% 0.00% 17.37% 14.84% 12.82% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
34 28 22 51 19 23 28 32 5.40 49 -35
NOPAT Margin
15.61% 10.39% 6.89% 15.74% 6.31% 6.49% 8.55% 8.97% 1.57% 10.09% -7.84%
Net Nonoperating Expense Percent (NNEP)
-0.74% 1.48% 15.26% 9.26% -0.07% 3.10% 0.14% -1.31% 0.59% 2.41% 4.13%
Return On Investment Capital (ROIC_SIMPLE)
- 3.20% - - - 2.26% 2.79% 2.99% 0.27% 2.46% -1.77%
Cost of Revenue to Revenue
29.30% 29.15% 29.25% 28.72% 28.90% 28.71% 28.74% 30.87% 30.55% 29.01% 27.34%
SG&A Expenses to Revenue
52.06% 59.10% 65.45% 55.65% 61.83% 61.42% 57.94% 55.36% 67.20% 57.19% 71.03%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
52.06% 59.10% 65.45% 55.65% 61.83% 61.42% 57.94% 55.36% 67.20% 57.19% 83.86%
Earnings before Interest and Taxes (EBIT)
39 34 16 51 32 30 47 54 5.84 66 -49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
46 43 28 62 45 37 60 67 24 88 -23
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
11.58 12.97 16.93 16.75 8.45 9.22 4.65 8.71 6.60 3.90 3.17
Price to Tangible Book Value (P/TBV)
22.08 183.58 141.54 82.87 36.01 32.93 16.66 26.86 0.00 0.00 0.00
Price to Revenue (P/Rev)
7.81 8.95 10.63 10.41 5.05 5.43 2.70 5.22 5.42 2.98 2.19
Price to Earnings (P/E)
49.19 61.58 85.23 96.43 56.93 71.90 31.59 71.64 91.86 43.63 136.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.03% 1.62% 1.17% 1.04% 1.76% 1.39% 3.17% 1.40% 1.09% 2.29% 0.74%
Enterprise Value to Invested Capital (EV/IC)
14.28 10.12 13.85 13.94 7.11 7.65 4.20 7.96 4.55 2.86 2.43
Enterprise Value to Revenue (EV/Rev)
7.67 9.17 10.78 10.55 5.18 5.57 2.78 5.28 5.90 3.41 2.54
Enterprise Value to EBITDA (EV/EBITDA)
37.61 48.17 58.94 65.37 34.79 41.29 17.89 33.64 42.29 21.60 26.43
Enterprise Value to EBIT (EV/EBIT)
44.34 57.09 73.13 84.84 47.31 56.33 22.91 43.76 59.98 30.02 54.37
Enterprise Value to NOPAT (EV/NOPAT)
47.92 61.89 81.42 89.86 53.50 63.53 29.97 69.43 86.40 42.99 86.75
Enterprise Value to Operating Cash Flow (EV/OCF)
53.37 121.75 155.09 243.28 195.10 208.68 27.27 44.41 47.52 21.06 19.55
Enterprise Value to Free Cash Flow (EV/FCFF)
79.56 0.00 0.00 0.00 0.00 0.00 73.84 105.24 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.12 0.43 0.41 0.37 0.35 0.33 0.34 0.32 0.75 0.73 0.77
Long-Term Debt to Equity
0.11 0.27 0.25 0.23 0.22 0.20 0.34 0.32 0.73 0.70 0.72
Financial Leverage
-0.11 0.17 0.09 0.06 0.04 0.27 0.19 0.16 0.44 0.43 0.36
Leverage Ratio
1.48 1.67 1.64 1.58 1.59 1.72 1.69 1.67 1.90 1.86 1.93
Compound Leverage Factor
1.50 1.47 1.12 1.47 1.41 1.51 1.59 1.59 -1.30 1.51 2.36
Debt to Total Capital
10.87% 30.12% 28.97% 27.15% 26.09% 24.89% 25.23% 24.18% 42.85% 42.15% 43.36%
Short-Term Debt to Total Capital
0.90% 11.42% 11.09% 10.66% 10.18% 9.81% 0.00% 0.00% 1.13% 1.49% 2.82%
Long-Term Debt to Total Capital
9.96% 18.70% 17.89% 16.49% 15.91% 15.08% 25.23% 24.18% 41.72% 40.66% 40.55%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
89.13% 69.88% 71.03% 72.85% 73.91% 75.11% 74.77% 75.82% 57.15% 57.85% 56.64%
Debt to EBITDA
0.40 1.56 1.40 1.44 1.42 1.45 1.26 1.22 4.42 3.53 5.51
Net Debt to EBITDA
-0.67 1.13 0.82 0.84 0.88 1.03 0.53 0.41 3.41 2.71 3.66
Long-Term Debt to EBITDA
0.37 0.97 0.86 0.87 0.86 0.88 1.26 1.22 4.30 3.40 5.15
Debt to NOPAT
0.51 2.01 1.93 1.97 2.18 2.23 2.11 2.51 9.03 7.02 18.07
Net Debt to NOPAT
-0.85 1.46 1.14 1.15 1.36 1.58 0.89 0.85 6.97 5.39 12.02
Long-Term Debt to NOPAT
0.47 1.25 1.19 1.20 1.33 1.35 2.11 2.51 8.79 6.77 16.90
Altman Z-Score
16.59 10.36 14.19 15.13 8.29 9.66 5.68 9.62 4.57 3.26 2.45
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.86 1.50 1.60 1.77 1.78 1.90 3.05 3.26 2.70 2.76 2.35
Quick Ratio
1.67 0.64 0.78 0.88 0.78 0.89 1.55 1.86 1.33 1.52 1.38
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-15 -415 -418 -411 -457 -118 -44 -3.03 -905 -814 -873
Operating Cash Flow to CapEx
3,288.10% -379.09% 1,383.74% 162.98% 688.11% -291.15% 1,230.67% 383.83% 341.87% 897.36% 5,435.44%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1,343.37 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.74 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 24.58 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.19 1.07 1.19 1.22 1.23 1.10 1.11 1.07 0.78 0.85 0.90
Accounts Receivable Turnover
10.89 9.51 10.68 9.20 10.44 8.43 10.52 8.16 9.20 8.04 10.89
Inventory Turnover
2.04 1.85 2.20 2.21 1.83 1.79 2.00 2.13 1.69 2.08 2.35
Fixed Asset Turnover
92.49 82.69 93.73 104.72 105.03 79.68 61.44 50.46 46.20 46.97 46.57
Accounts Payable Turnover
5.61 5.03 5.33 4.94 4.49 5.44 4.93 5.10 4.06 6.49 5.65
Days Sales Outstanding (DSO)
33.51 38.40 34.17 39.69 34.96 43.28 34.71 44.72 39.68 45.40 33.53
Days Inventory Outstanding (DIO)
179.02 197.44 166.05 164.96 199.50 203.42 182.90 171.43 215.42 175.84 155.19
Days Payable Outstanding (DPO)
65.04 72.53 68.48 73.84 81.32 67.05 74.03 71.64 89.91 56.25 64.62
Cash Conversion Cycle (CCC)
147.50 163.32 131.75 130.81 153.14 179.65 143.58 144.51 165.19 164.99 124.10
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
412 806 797 857 888 948 869 891 1,799 1,812 1,706
Invested Capital Turnover
1.98 1.52 1.78 1.81 1.87 1.48 1.58 1.54 1.03 1.10 1.27
Increase / (Decrease) in Invested Capital
49 443 440 463 476 142 72 35 911 864 838
Enterprise Value (EV)
5,876 8,160 11,035 11,941 6,308 7,253 3,649 7,096 8,176 5,185 4,155
Market Capitalization
5,981 7,967 10,881 11,787 6,148 7,072 3,541 7,010 7,516 4,535 3,579
Book Value per Share
$9.48 $11.13 $11.58 $12.58 $12.91 $13.62 $13.49 $14.29 $20.08 $19.48 $19.14
Tangible Book Value per Share
$4.97 $0.79 $1.39 $2.54 $3.03 $3.81 $3.77 $4.63 ($5.08) ($4.28) ($4.67)
Total Capital
579 879 905 966 985 1,022 1,018 1,062 1,993 2,009 1,996
Total Debt
63 265 262 262 257 254 257 257 854 847 866
Total Long-Term Debt
58 164 162 159 157 154 257 257 832 817 809
Net Debt
-105 192 154 153 160 180 108 87 660 650 576
Capital Expenditures (CapEx)
0.85 4.52 2.68 0.79 1.62 5.05 11 7.10 6.85 6.62 1.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)
121 180 170 225 247 292 215 248 273 280 220
Debt-free Net Working Capital (DFNWC)
288 252 278 334 343 365 364 418 468 477 509
Net Working Capital (NWC)
283 152 178 231 243 265 364 418 445 447 453
Net Nonoperating Expense (NNE)
0.37 1.26 7.60 3.50 -0.02 5.78 0.18 -1.57 2.41 10.00 14
Net Nonoperating Obligations (NNO)
-105 192 154 153 160 180 108 87 660 650 576
Total Depreciation and Amortization (D&A)
6.75 8.28 12 11 13 7.23 13 13 19 22 27
Debt-free, Cash-free Net Working Capital to Revenue
15.74% 20.18% 16.61% 19.84% 20.25% 22.39% 16.35% 18.45% 19.74% 18.45% 13.43%
Debt-free Net Working Capital to Revenue
37.65% 28.35% 27.18% 29.47% 28.20% 28.07% 27.67% 31.11% 33.77% 31.40% 31.13%
Net Working Capital to Revenue
36.97% 17.07% 17.38% 20.37% 19.97% 20.37% 27.67% 31.11% 32.14% 29.43% 27.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.61 $0.49 $0.25 $0.85 $0.34 $0.31 $0.49 $0.59 $0.05 $0.66 ($0.85)
Adjusted Weighted Average Basic Shares Outstanding
54.43M 55.14M 54.75M 55.97M 56.35M 56.36M 56.21M 56.33M 58.36M 59.29M 58.26M
Adjusted Diluted Earnings per Share
$0.58 $0.46 $0.24 $0.81 $0.33 $0.30 $0.48 $0.58 $0.05 $0.65 ($0.84)
Adjusted Weighted Average Diluted Shares Outstanding
57.44M 58.03M 57.79M 58.55M 58.48M 58.35M 58.35M 57.68M 59.59M 60.19M 59.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
55.20M 55.51M 55.94M 56.39M 56.33M 56.40M 56.33M 56.73M 59.64M 59.05M 59.44M
Normalized Net Operating Profit after Tax (NOPAT)
34 28 12 35 19 23 28 32 5.40 49 -35
Normalized NOPAT Margin
15.61% 10.39% 3.71% 10.94% 6.31% 6.49% 8.55% 8.97% 1.57% 10.09% -7.84%
Pre Tax Income Margin
18.44% 11.23% 3.48% 14.56% 9.28% 7.40% 13.24% 14.45% -1.16% 11.00% -13.47%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.66 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.01 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.50 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.15 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 59.83% 0.00% 61.09% 96.19% 189.93%

Financials Breakdown Chart

Key Financial Trends

e.l.f. Beauty has delivered explosive growth over the last few years, but recent quarters show that profitability has become more volatile as spending, debt, and working-capital swings weigh on results.

  • Revenue has continued to rise strongly over the multi-year period, reaching $449.3 million in Q4 2026 versus $321.1 million in Q4 2025 and $216.3 million in Q1 2024, showing the brand is still gaining scale.
  • Gross profit also improved meaningfully year over year, with Q4 2026 gross profit at $326.5 million on revenue of $449.3 million, indicating solid product economics even as costs moved around.
  • Cash from operations was strong in Q4 2026 at $102.5 million, suggesting the core business can still generate meaningful cash even in a quarter with a net loss.
  • The balance sheet remains sizable, with $2.32 billion in assets and $1.16 billion in equity at Q3 2026, giving the company a substantial operating base.
  • Cash and equivalents increased from $194.4 million in Q2 2026 to $196.8 million in Q3 2026, and then the company generated another $92.9 million net change in cash in Q4 2026.
  • Operating margins have been inconsistent. Q3 2026 showed strong operating income of $67.5 million, but Q4 2026 swung to an operating loss of $50.3 million.
  • SG&A remains the key swing factor. In Q4 2026, SG&A was $319.1 million versus gross profit of $326.5 million, leaving very little cushion before operating profit turns negative.
  • Debt is still material. At Q3 2026, the company carried $30.0 million of short-term debt and $816.7 million of long-term debt.
  • Q4 2026 net income was a loss of $49.4 million, compared with a profit of $39.4 million in Q3 2026, highlighting how quickly earnings can reverse.
  • Working capital was a drag in several periods, especially when changes in operating assets and liabilities turned sharply negative, which can pressure reported cash flow even when sales are growing.

Looking at the trend over the last four years, e.l.f. Beauty has clearly scaled from a much smaller company into a far larger one, with revenue and assets rising sharply. That said, the latest quarter shows that the company is still vulnerable to heavy operating expenses, interest costs, and debt-related financing activity. Investors should watch whether management can translate top-line growth into steadier operating leverage and more consistent earnings.

06/03/26 11:43 AM ETAI Generated. May Contain Errors.

e.l.f. Beauty Financials - Frequently Asked Questions

According to the most recent income statement we have on file, e.l.f. Beauty's financial year ends in March. Their financial year 2026 ended on March 31, 2026.

e.l.f. Beauty's net income appears to be on an upward trend, with a most recent value of $26.32 million in 2026, rising from $4.36 million in 2015. The previous period was $112.09 million in 2025. See e.l.f. Beauty's forecast for analyst expectations on what's next for the company.

e.l.f. Beauty's total operating income in 2026 was $73.63 million, based on the following breakdown:
  • Total Gross Profit: $1.16 billion
  • Total Operating Expenses: $1.08 billion

Over the last 10 years, e.l.f. Beauty's total revenue changed from $191.41 million in 2015 to $1.64 billion in 2026, a change of 754.9%.

e.l.f. Beauty's total liabilities were at $1.26 billion at the end of 2026, a 159.3% increase from 2025, and a 463.7% increase since 2015.

In the past 10 years, e.l.f. Beauty's cash and equivalents has ranged from $10.06 million in 2017 to $289.69 million in 2026, and is currently $289.69 million as of their latest financial filing in 2026.

Over the last 10 years, e.l.f. Beauty's book value per share changed from -1,978.77 in 2015 to 19.14 in 2026, a change of -101.0%.



Financial statements for NYSE:ELF last updated on 5/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners